News & Updates
Filter by Specialty:

Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
A programme targeting 9,000 adults 18–44 years of age will identify individuals with high 10-year risk of diabetes through DNA testing and provide precision preventive intervention.
Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
07 Nov 2025
High BMI tied to ulnar nerve entrapment development in nondiabetic individuals
A longitudinal study from Sweden shows an association between high BMI and the development of ulnar nerve entrapment (UNE) in a middle-aged cohort of individuals without diabetes from northern Europe, with over 25 years of follow-up.
High BMI tied to ulnar nerve entrapment development in nondiabetic individuals
06 Nov 2025
SGLT-2i lowers autoimmune rheumatic disease risk in T2D
The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, results in a reduced risk of autoimmune rheumatic disease among adults with type 2 diabetes (T2D), reports a recent study.
SGLT-2i lowers autoimmune rheumatic disease risk in T2D
04 Nov 2025
Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D
In patients with type 2 diabetes (T2D), empagliflozin 25 mg daily offers greater kidney protection than its 10 mg daily dose or dapagliflozin 10 mg daily, a retrospective cohort study in Hong Kong has shown.
Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D
03 Nov 2025
Free school meals tied to improved child health
A US cohort study of schools matched to child and adolescent patient medical records from a network of community health organizations found an association between school participation in the Community Eligibility Provision (CEP) programme and a net reduction in blood pressure (BP) outcomes.




